ABSTRACT
4

Introduction
48
As one of the most common perinatal complications of pregnancy, non-diabetic 49 macrosomia (NDFMS) has a serious impact on the long-term health of the baby. To 50 explore the potential causes and mechanisms of NDFMS is significant to reduce the 51 incidence of NDFMS and improve perinatal maternal, child health, and infant 52 long-term health. and play an important role in pregnancy (6, 7). However, the underlying mechanism is 62 still unclear. Previous studies confirmed a variety of miRNAs with abnormal 63 expression in placental tissues are related to fetal growth and development (8-10). The 64 results of Jiang et al. (11) showed miR-21 expression was up-regulated in NDFMS, 65 which speculated miR-21 might be involved in the occurrence of NDFMS.
66
So far, there was no study on the patterns of miRNA expression in placental tissues 67 of NDFMS. We screened out miRNAs with abnormal expression in NDFMS placental 68 tissues through miRNA microarray, and studied the mechanism of key miRNA in this 69 5 study.
70
Results
71
Clinical data
72
Clinical characteristics of the study population are summarized in Table 1 
qRT-PCR validation in placentas
85
Twelve miRNAs (miR-331-3p, miR-204-5p, miR-106b-5p, miR-370-3p, 86 miR-205-5p, miR-141-3p, miR-126-3p, miR-424-5p, miR-194-5p, miR-411-5p, 87 miR-1291, and miR-1283) mentioned above were screened out from the perspective 88 of bioinformatics, conservatism and practicality (Table S3) -331-3p, miR-370-3p, miR-141-3p, miR-126-3p, miR-424-5p, and 92 miR-411-5p were statistically different between NDFMS and normal controls, and P 93 values were 0.047, 0.034, < 0.001, 0.023, 0.031, and 0.040, respectively (Fig. S2 ).
94
Considering P-value and the fold change of expression, miR-141-3p was determined 95 as the key miRNA (Fig. 1A) , and fetal birth weight gradually increased along with the 96 increased expression of miR-141-3p as the correlation analysis performed (P = 0.019, 97 r 2 = 0.101) (Fig. 1B) , so we mainly explored the function of miR-141-3p in NDFMS. inhibitors had no effect (Fig. 2D, 2E ).
109
Targeting PLAG1 by miR-141-3p
110
In the prediction analysis, we identified 19 target genes of miR-141-3p. We 111 examined the expression levels of the 19 genes (Fig. S3) , and found only PLAG1 was 112 significantly decreased after transfected with miR-141-3p mimics (P < 0.001) ( (Fig. 3B) . Additionally, the expression of PLAG1 gene in NDFMS placentas
115
was significantly lower than that in controls (P = 0.007) (Fig. 4) .
116
When overexpression of miR-141-3p and PLAG1 at the same time, we found 117 proliferation and invasion ability could be reversed by PLAG1 on the basis of 118 increased by miR-141-3p induced at 48 h ( as expected. Moreover, further studies are still needed to confirm this conclusion.
153
We found PLAG1 is a target gene of miR-141-3p, which is a member of 
Cell invasion analysis
244
The treated cells were transferred to the transwell chamber with 100 μl empty at least in four software as the target genes.
264
C57BL/6J mice feeding and experiment
265
We used miR-141-3p agomir (microON TM miR-141-3p agomir) (RiboBio,
266
Guangzhou, China) to construct miR-141-3p overexpression model in placental and sacrificed at 10 days after the second treatment, and observed weight fluctuation
275
(The results of effect on body weight and food intake were shown in Fig. S1 ). were in normal distribution, the student's t-test was used to compare two groups.
276
Statistical analysis
279
Otherwise, the Mann-Whitney U-test were used. All results are expressed as mean ± 280 standard error (X ± S.E.) without special instructions. P < 0.05 was considered 281 statistically significant. P < 0.05: * , P < 0.01: ** , P < 0.001: *** .
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